Drug application
BUPROPION HYDROBROMIDE (BUPROPION HYDROBROMIDE)
Drugs@FDA ANDA 200835 · WATSON LABS INC
Key facts
| Drug name | BUPROPION HYDROBROMIDE |
|---|---|
| Active ingredients | BUPROPION HYDROBROMIDE |
| Application type | ANDA |
| Application number | 200835 |
| Company | WATSON LABS INC |
| Dosage forms | TABLET, EXTENDED RELEASE, ORAL |
| Strength | 174MG |
| Marketing status | None (Tentative Approval) |
| Reference listed drug | No |
| Latest submission class | Not Applicable |
| Latest submission status date | Aug 13, 2013 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.